Eye Institute Limited

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Glaucoma1 trial
• Macular degeneration1 trial

Phase

• Phase 12 trials

Status

• Completed2 trials

Lead sponsor

• ONL Therapeutics2 trials

Closed trials

• Completed

  A Phase 1b Study of ONL1204 Ophthalmic Solution in Patients with Progressing Open Angle Glaucoma

  NCT05160805· Phase 1· ONL Therapeutics· Source

• Completed

  ONL1204 Ophthalmic Solution in Patients With Geographic Atrophy Associated With Age-related Macular Degeneration

  NCT04744662· Phase 1· ONL Therapeutics· Source